Arctoris appoints three experienced industry executives as members of its Advisory Board
Joining Arctoris in senior roles are Beth J Hoffman PhD, Prof Khusru Asadullah MD and Stanley Lapidus (left to right) OXFORD, UK – 8 December 2020. Arctoris Ltd, an Oxford-based research company operating a fully automated drug discovery platform, has appointed three distinguished experts as members of its Advisory Board: Beth J Hoffman PhD, Professor Khusru […]
Arctoris and Syntekabio Form Research Partnership
Syntekabio and Arctoris join their forces in the fight against COVID-19. Together, they substantially accelerate drug discovery by combining their leading technologies: Syntekabio’s in silico modeling simulation and Arctoris’ fully-automated in vitro validation. OXFORD, UK – 8 September 2020. Arctoris, the creator of the world’s first fully automated drug discovery platform, has signed a Memorandum of […]
Insilico Medicine and Arctoris to collaborate on COVID-19 by combining robotics and AI
Insilico Medicine and Arctoris to collaborate on COVID-19 by combining robotics and AI (Credit: Insilico) OXFORD, UK – 09 July 2020. Insilico Medicine, a biotechnology company developing an end-to-end drug discovery pipeline utilizing next-generation artificial intelligence, today announced a technology partnership with Arctoris, the world’s first fully automated drug discovery platform, offering remotely accessible, pre-optimised and fully […]
Arctoris contributes its capabilities and expertise to the fight against COVID-19
OXFORD, UK – 07 July 2020. Arctoris Ltd. supports global research efforts to find new therapeutics against COVID-19. Scientists in academic centres and companies around the world desperately search for novel therapeutics and vaccines to treat and prevent COVID-19. However, with lockdowns and limited access to laboratories, researchers are being forced to work from home, putting research […]
BioTarget 2019 winners
BioTarget 2019 finalists compete in a pitch finale held in London, UK OXFORD, UK – 11 June 2019 Eight biotech companies from around the world were selected as finalists to compete for free experimentation worth $170,000 on the Arctoris robotic system. A distinguished panel – including Sonal Patel (VP, Oncology Lead, Johnson & Johnson), Jackie […]
Reproducibility film
Arctoris co-founder & CEO Martin-Immanuel Bittner features in a short film about reproducibility and open data in drug discovery OXFORD, UK – 19 June 2019 A short film about reproducibility and open data in drug discovery was officially released to the public in Berlin, Germany, at an event organised by the Young Academy of the […]
Arctoris secures £3.2M
Arctoris secures seed funding of £3.2 million to advance novel drug discovery platform powered by robotics OXFORD, UK – 30 September 2019 Arctoris Ltd today announced that it has successfully closed a seed funding round of £3.2 million to advance its novel drug discovery offering. The funding will be used to further build out the […]
Arctoris expands senior team
Arctoris strengthens senior team to continue the development of its on-demand drug discovery services. Joining Arctoris in senior roles are Professor John Mattick, Member of the Board of Directors (left) & Dr Daniel Thomas, Head of Discovery Biology (right) OXFORD, UK – 13 November 2019 Arctoris Ltd today announced the appointment of Professor John Mattick AO FAA […]
Arctoris opens new facility
Arctoris successfully moves into its new global headquarters in Oxford, UK OXFORD, UK – 11 December 2019 Arctoris Ltd, the developer of the world’s first fully automated drug discovery platform, today opened the doors to its new global headquarters and state-of-the-art research and development (R&D) facility in Oxford, UK. Housing the company’s proprietary technology and […]
BioTarget 2020 launch
Arctoris launches BioTarget 2020 competition to support innovation in emerging biotech companies OXFORD, UK – 21 February, 2020 Arctoris Ltd has announced the 2nd edition of BioTarget, a global business competition for drug discovery entrepreneurs. BioTarget 2020 is now open for applications. BioTarget is a non-profit initiative, sponsored by Arctoris Ltd and leading investment management firm Baillie […]